Ann: BTM delivers positive First in Man results in Cell Therapies, page-101

  1. 2,024 Posts.
    lightbulb Created with Sketch. 449
    My moderated post repeated here with the “profanity” covered:

    So basically all you offer is mere opinion. Usually that’s fine, but you purport to offer insights that others are blind to or are poor victims of spin that you and the shorts can see through. Given that it’s only reasonable to put the bunsen to your backside.

    The questions you ask about profitability could have been answered by a quick look at last FY results — yes, they were profitable. You offer no reasons to back your suggestion that profitability might not continue this FY, just as you offer no reasons to back your opinion that today’s was underwhelming.

    As the saying goes, opinions are like a*******s everyone has one.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.19
Change
-0.035(2.87%)
Mkt cap ! $818.6M
Open High Low Value Volume
$1.19 $1.20 $1.15 $1.635M 1.394M

Buyers (Bids)

No. Vol. Price($)
2 18287 $1.17
 

Sellers (Offers)

Price($) Vol. No.
$1.19 42827 3
View Market Depth
Last trade - 16.15pm 23/06/2025 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.